Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2018

01-08-2018

A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic

Authors: Jamal H. Mahar, Ihab Haddadin, Divyajot Sadana, Abishek Gadre, Natalie Evans, Deborah Hornacek, Natalia Fendrikova Mahlay, Marcelo Gomes, Douglas Joseph, Maya Serhal, Michael Zhen-Yu Tong, Seth R. Bauer, Michael Militello, Bernard Silver, Mehdi Shishehbor, John R. Bartholomew, Gustavo A. Heresi

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2018

Login to get access

Abstract

Management of intermediate and high risk acute pulmonary embolism (PE) is challenging. The role of multidisciplinary teams for the care of these patients is emerging. Herein, we report our experience with a pulmonary embolism response team (PERT). We conducted a retrospective chart review on all patients admitted to the Cleveland Clinic main campus who required activation of the (PERT) from October 1, 2014 to September 1, 2016. We extracted data pertaining to clinical presentation, bleeding complications, and pre- and post-discharge imaging. Patients were classified as low, intermediate or high risk PE. Descriptive and continuous variables were collected and analyzed. There were 134 PERT activations. PE was confirmed by CT-PA in 118 patients. Fifteen (13%) patients were classified as low risk, 80 (68%) intermediate risk PE and 23 (19%) high risk PE. Fourteen (12%) patients were treated with catheter directed rtPA, 6 (5%) received full dose (100 mg rtPA), 16 (13%) received systemic half-dose (50 mg rtPA), 6 (5%) underwent a surgical embolectomy and 4 (3%) underwent mechanical thrombectomy. 65 (55%) patients received anticoagulation only, and 8 (7%) patients were managed conservatively without any anticoagulation or advanced therapy. 11 (9%) patients died while during the hospitalization. Fourteen patients had major bleeding events. There were no bleeding events among patients who received systemic low dose or full dose rtPA. A multidisciplinary approach to cases of intermediate risk and high risk PE can be implemented successfully. We saw a relatively low rate of bleeding events with use of rtPA.
Literature
1.
go back to reference Wiener RS, Schwartz LM, Woloshin S (2011) Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 09(9):831–837 171( Wiener RS, Schwartz LM, Woloshin S (2011) Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 09(9):831–837 171(
2.
go back to reference Fanikos J, Rao A, Seger AC, Carter D, Piazza G, Goldhaber SZ (2013) Hospital costs of acute pulmonary embolism. Am J Med 126(2):127–132CrossRefPubMed Fanikos J, Rao A, Seger AC, Carter D, Piazza G, Goldhaber SZ (2013) Hospital costs of acute pulmonary embolism. Am J Med 126(2):127–132CrossRefPubMed
3.
go back to reference Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 26(16):1788–1830CrossRef Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 26(16):1788–1830CrossRef
4.
go back to reference Kucher N, Boekstegers P, Muller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T et al (2014) Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 129(4):479–486CrossRefPubMed Kucher N, Boekstegers P, Muller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T et al (2014) Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 129(4):479–486CrossRefPubMed
5.
go back to reference Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M (2013) Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 15(2):273–277 111(CrossRef Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M (2013) Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 15(2):273–277 111(CrossRef
6.
go back to reference Barnes GD, Kabrhel C, Courtney DM, Naydenov S, Wood T, Rosovsky R et al (2016) Diversity in the pulmonary embolism response team model: an organizational survey of the National PERT Consortium Members. Chest 150(6):1414–1417CrossRefPubMed Barnes GD, Kabrhel C, Courtney DM, Naydenov S, Wood T, Rosovsky R et al (2016) Diversity in the pulmonary embolism response team model: an organizational survey of the National PERT Consortium Members. Chest 150(6):1414–1417CrossRefPubMed
7.
go back to reference Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692–694CrossRefPubMed Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692–694CrossRefPubMed
8.
go back to reference Alviar CL, Heresi GA (2016) Thrombolysis in submassive pulmonary embolism: Finding the balance. Cleve Clin J Med 83(12):933–936CrossRefPubMed Alviar CL, Heresi GA (2016) Thrombolysis in submassive pulmonary embolism: Finding the balance. Cleve Clin J Med 83(12):933–936CrossRefPubMed
9.
go back to reference Serhal M, Haddadin IS, Heresi GA, Hornacek DA, Shishehbor MH, Bartholomew JR (2017) Pulmonary embolism response teams. J Thromb Thrombolysis 44(1):19–29CrossRefPubMed Serhal M, Haddadin IS, Heresi GA, Hornacek DA, Shishehbor MH, Bartholomew JR (2017) Pulmonary embolism response teams. J Thromb Thrombolysis 44(1):19–29CrossRefPubMed
10.
go back to reference Kabrhel C, Rosovsky R, Channick R, Jaff MR, Weinberg I, Sundt T et al (2016) A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest 150(2):384–393CrossRefPubMed Kabrhel C, Rosovsky R, Channick R, Jaff MR, Weinberg I, Sundt T et al (2016) A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest 150(2):384–393CrossRefPubMed
11.
go back to reference Barnes G, Giri J, Courtney DM, Naydenov S, Wood T, Rosovsky R et al (1995) Nuts and bolts of running a pulmonary embolism response team: results from an organizational survey of the National PERT Consortium members. Hosp Pract 45:76–80CrossRef Barnes G, Giri J, Courtney DM, Naydenov S, Wood T, Rosovsky R et al (1995) Nuts and bolts of running a pulmonary embolism response team: results from an organizational survey of the National PERT Consortium members. Hosp Pract 45:76–80CrossRef
12.
go back to reference Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M et al (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378(9785):41–48CrossRefPubMed Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M et al (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378(9785):41–48CrossRefPubMed
13.
go back to reference Curtis GM, Lam SW, Reddy AJ, Bauer SR (2014) Risk factors associated with bleeding after alteplase administration for pulmonary embolism: a case-control study. Pharmacotherapy 34(8):818–825CrossRefPubMed Curtis GM, Lam SW, Reddy AJ, Bauer SR (2014) Risk factors associated with bleeding after alteplase administration for pulmonary embolism: a case-control study. Pharmacotherapy 34(8):818–825CrossRefPubMed
14.
go back to reference Poterucha TJ, Bergmark B, Aranki S, Kaneko T, Piazza G (2015) Surgical Pulmonary embolectomy. Circulation 132(12):1146–1151CrossRefPubMed Poterucha TJ, Bergmark B, Aranki S, Kaneko T, Piazza G (2015) Surgical Pulmonary embolectomy. Circulation 132(12):1146–1151CrossRefPubMed
Metadata
Title
A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic
Authors
Jamal H. Mahar
Ihab Haddadin
Divyajot Sadana
Abishek Gadre
Natalie Evans
Deborah Hornacek
Natalia Fendrikova Mahlay
Marcelo Gomes
Douglas Joseph
Maya Serhal
Michael Zhen-Yu Tong
Seth R. Bauer
Michael Militello
Bernard Silver
Mehdi Shishehbor
John R. Bartholomew
Gustavo A. Heresi
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2018
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1686-2

Other articles of this Issue 2/2018

Journal of Thrombosis and Thrombolysis 2/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.